|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||
Aims of Study.
Human cadaver allografts
are gaining popularity for use in pubovaginal slings and vaginal reconstruction.
The purpose of this study was to determine the presence of DNA and quantitate
the concentration of DNA in two commercially available cadaver allografts:
freeze-dried-gamma-irradiated cadaver fascia lata and decellularized cadaver
dermis.
Methods.
Sixteen samples
from two commercial sources of human allograft were evaluated: freeze-dried-gamma-irradiated
cadaver fascia lata (8 samples); decellularized cadaver dermis (8 samples).
Fresh human rectus fascia served as a positive control; sterile saline
served as a negative control. All samples underwent a standard extraction
technique (proteinase K/ SDS/ phenol) to isolate DNA. Polymerase chain
reaction was performed to amplify the retrieved DNA material.
Spectophotometric evaluation was used to quantify DNA concentrations.
Results.
Of the group, 14/16
(87.5%) samples tested from two commercial sources of human allograft
fascia contained DNA. Mean DNA
concentrations were 258.3 ± 80.1µg/g tissue for cadaver fascia
lata group vs 272.8 ± 168.8 µg/g tissue for cadaver dermis
group. PCR amplified DNA segments
of 2000 bp from both cadaver fascia lata (1/8 samples) and cadaver dermis
group (1/8 samples).
Conclusions.
Both freeze-dried-gamma-irradiated
cadaver fascia lata and decellularized cadaver dermis contained DNA. Whether
this genetic material is associated with infectious risk remains unknown.
Unusual diseases such as Creutzfield-Jacob disease may pose additional
risk with cadaver allografts.